RATE Registry - Registry of Atrial Tachyarrhythmia/Atrial Fibrillation (AT/AF) Episodes in the Cardiac Rhythm Management (CRM) Device Population
RATE
Registry of AT/AF Episodes in the CRM Device Population: RATE Registry
1 other identifier
observational
5,379
1 country
1
Brief Summary
The purpose of this registry is to produce a prospective, outcome-oriented registry to document the prevalence of AT/AF in the CRM population by using the Advanced AT/AF Diagnostics in select SJM devices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2006
CompletedFirst Submitted
Initial submission to the registry
February 4, 2009
CompletedFirst Posted
Study publicly available on registry
February 5, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2012
CompletedFebruary 4, 2019
February 1, 2019
5.5 years
February 4, 2009
February 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Prevalence of atrial tachycardia and atrial fibrillation in a cardiac rhythm management population
24 months
Secondary Outcomes (3)
Development or exacerbation of HF
2 years
Development of AF
2 years
AT/AF burden
2 years
Study Arms (1)
No history of AF
Patient should not have had a documented history of AF for a period of 3 months prior to enrollment.
Interventions
Eligibility Criteria
Patients with a CRM device
You may qualify if:
- Patient is implanted with a CRM device
- Patient has no documented history of AF (3 months prior to enrollment)
- Patient is \>18 years of age
- Patient has life expectancy of \>24 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Jude Medical
Sylmar, California, 91342, United States
Related Publications (2)
Orlov MV, Olshansky B, Benditt DG, Kotler G, McIntyre T, Fujian Qu, Turkel M, Gorev M, Poghosyan H, Waldo AL. Is competitive atrial pacing a possible trigger for atrial fibrillation? Observations from the RATE registry. Heart Rhythm. 2021 Jan;18(1):3-9. doi: 10.1016/j.hrthm.2020.07.028. Epub 2020 Jul 30.
PMID: 32738404DERIVEDSwiryn S, Orlov MV, Benditt DG, DiMarco JP, Lloyd-Jones DM, Karst E, Qu F, Slawsky MT, Turkel M, Waldo AL; RATE Registry Investigators. Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes. Circulation. 2016 Oct 18;134(16):1130-1140. doi: 10.1161/CIRCULATIONAHA.115.020252.
PMID: 27754946DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Albert Waldo, MD
University Hospitals Cleveland Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2009
First Posted
February 5, 2009
Study Start
October 1, 2006
Primary Completion
April 1, 2012
Study Completion
April 1, 2012
Last Updated
February 4, 2019
Record last verified: 2019-02